DPP-4 has two mechanisms of action: first as a membrane spanning protein, where it binds and activates adenosine deaminase complexing protein and transfers intracellular signals via dimerization
For patients who may benefit from GLP-1based therapies but face cost or availability barriers, it may be valuable to explore whether alternative regulatory mechanisms could help balance safety oversight with broader access
183 HSP70B promotes breast cancer metastasis by upregulating mesenchymal markers such as N-cadherin, MMP2, SNAIL, and vimentin, facilitating EMT
10.1097/MCG.0b013e3181e12c24 79 WangP.FangY.QiuJ.ZhouY.WangZ.JiangC
However, while BPC-157 has been marketed online and has gained attention through patents and anecdotal reports, it has not yet been approved by major medical regulatory bodies like the FDA, mainly due to the lack of human clinical trials